International Society of Cardiovascular Infectious Diseases Guidelines for the Diagnosis, Treatment and Prevention of Disseminated Mycobacterium chimaera Infection Following Cardiac Surgery with Cardiopulmonary Bypass.

Select Content Type
Clinical Guidelines
Authored By
Hasse B, Hannan MM, Keller PM, Maurer FP, Sommerstein R, Mertz D, Wagner D, Fernández-Hidalgo N, Nomura J, Manfrin V, Bettex D, Hernandez Conte A, Durante-Mangoni E, Tang TH, Stuart RL, Lundgren J, Go
Authored On
Interests
Cardiology
Pulmonology
Infectious Disease & Vaccines
Speciality
Cardiology
Pulmonology
Infectious Disease & Vaccines
Book Detail
volume
104
ISSN
1532-2939
Publication Date
Actions
Download in App
Event Data
{"article_title":"International Society of Cardiovascular Infectious Diseases Guidelines for the Diagnosis, Treatment and Prevention of Disseminated Mycobacterium chimaera Infection Following Cardiac Surgery with Cardiopulmonary Bypass.","author":"Hasse B","journal_title":"The Journal of hospital infection","issn":"1532-2939","isbn":"","publication_date":"2019 Jun","volume":"104","issue":"2","first_page":"214","page_count":"","accession_number":"31715282","doi":"10.1016\/j.jhin.2019.10.009","publisher":"W.B. Saunders For The Hospital Infection Society","doctype":"Journal Article","subjects":"United Kingdom; Cross Infection diagnosis; Cross Infection drug therapy; Cross Infection microbiology; Cross Infection prevention & control; Mycobacterium isolation & purification; Mycobacterium Infections, Nontuberculous diagnosis; Mycobacterium Infections, Nontuberculous drug therapy; Mycobacterium Infections, Nontuberculous prevention & control; Anti-Bacterial Agents therapeutic use; Cardiac Surgical Procedures adverse effects; Cardiac Surgical Procedures methods; Cardiology; Cardiopulmonary Bypass; Communicable Diseases; Equipment Contamination; Humans; Risk Factors; Societies, Medical; United Kingdom","interest_area":["Cardiology"," Pulmonology"," Infectious Disease & Vaccines"],"abstract":"Mycobacterial infection-related morbidity and mortality in patients following cardiopulmonary bypass surgery is high and there is a growing need for a consensus-based expert opinion to provide international guidance for diagnosing, preventing and treating in these patients. In this document the International Society for Cardiovascular Infectious Diseases (ISCVID) covers aspects of prevention (field of hospital epidemiology), clinical management (infectious disease specialists, cardiac surgeons, ophthalmologists, others), laboratory diagnostics (microbiologists, molecular diagnostics), device management (perfusionists, cardiac surgeons) and public health aspects. Copyright \u00a9 2019 The Author(s). Published by Elsevier Ltd.. All rights reserved.","url":"https:\/\/search.ebscohost.com\/login.aspx?direct=true&db=mdl&AN=31715282","isPdfLink":false,"isSAML":true,"additionalInfo":{"Authored_By":"Hasse B, Hannan MM, Keller PM, Maurer FP, Sommerstein R, Mertz D, Wagner D, Fern\u00e1ndez-Hidalgo N, Nomura J, Manfrin V, Bettex D, Hernandez Conte A, Durante-Mangoni E, Tang TH, Stuart RL, Lundgren J, Gordon S, Jarashow MC, Schreiber PW, Niemann S, Kohl TA, Daley CL, Stewardson AJ, Whitener CJ, Perkins K, Plachouras D, Lamagni T, Chand M, Freiberger T, Zweifel S, Sander P, Schulthess B, Scriven JE, Sax H, van Ingen J, Mestres CA, Diekema D, Brown-Elliott BA, Wallace RJ Jr, Baddour LM, Miro JM, Hoen B, Athan E, Bayer A, Barsic B, Corey GR, Chu VH, Durack DT, Fortes CQ, Fowler V, Hoen B, Krachmer AW, Durante-Magnoni E, Miro JM, Wilson WR","Corporate_Authors":"M. chimaera ISCVID Investigators and, ISCVID Executive Committee, Infectious Diseases Specialists, Hospital Epidemiologists, Microbiologists and Molecular Typing Specialists, Cardiac Surgeons\/ Perfusionists\/ Cardiologists, Ophthalmology, Anaesthesiologists, Public Health","Journal_Info":"Publisher: W.B. Saunders For The Hospital Infection Society Country of Publication: England NLM ID: 8007166 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-2939 (Electronic) Linking ISSN: 01956701 NLM ISO Abbreviation: J Hosp Infect Subsets: MEDLINE","Publication_Type":"Journal Article; Practice Guideline","Published_Date":"2020-02-01","Source":"The Journal of hospital infection [J Hosp Infect] 2020 Feb; Vol. 104 (2), pp. 214-235. Date of Electronic Publication: 2019 Nov 09.","Languages":"English","Electronic_ISSN":"1532-2939","MeSH_Terms":"Cross Infection*\/diagnosis , Cross Infection*\/drug therapy , Cross Infection*\/microbiology , Cross Infection*\/prevention & control , Mycobacterium*\/isolation & purification , Mycobacterium Infections, Nontuberculous*\/diagnosis , Mycobacterium Infections, Nontuberculous*\/drug therapy , Mycobacterium Infections, Nontuberculous*\/prevention & control, Anti-Bacterial Agents\/therapeutic use ; Cardiac Surgical Procedures\/adverse effects ; Cardiac Surgical Procedures\/methods ; Cardiology ; Cardiopulmonary Bypass ; Communicable Diseases ; Equipment Contamination ; Humans ; Risk Factors ; Societies, Medical ; United Kingdom","Subjects":"Anti-Bacterial Agents therapeutic use, Cardiac Surgical Procedures adverse effects, Cardiac Surgical Procedures methods, Cardiology, Cardiopulmonary Bypass, Communicable Diseases, Equipment Contamination, Humans, Risk Factors, Societies, Medical, United Kingdom, Cross Infection diagnosis, Cross Infection drug therapy, Cross Infection microbiology, Cross Infection prevention & control, Mycobacterium isolation & purification, Mycobacterium Infections, Nontuberculous diagnosis, Mycobacterium Infections, Nontuberculous drug therapy, Mycobacterium Infections, Nontuberculous prevention & control","Title_Abbreviations":"The Journal of hospital infection","Volume":"104"},"header":{"DbId":"mdl","DbLabel":"MEDLINE Ultimate","An":"31715282","RelevancyScore":"777","PubType":"Academic Journal","PubTypeId":"academicJournal","PreciseRelevancyScore":"777.158569335938"},"plink":"https:\/\/search.ebscohost.com\/login.aspx?direct=true&site=eds-live&db=mdl&AN=31715282&authtype=shib&custid=ns346513&group=main&profile=eds","upload_link":"https:\/\/dx.doi.org\/doi:10.1016\/j.jhin.2019.10.009"}
ISSN
1532-2939
IS_Ebsco
true
Additional Info
["Hasse B, Hannan MM, Keller PM, Maurer FP, Sommerstein R, Mertz D, Wagner D, Fern\u00e1ndez-Hidalgo N, Nomura J, Manfrin V, Bettex D, Hernandez Conte A, Durante-Mangoni E, Tang TH, Stuart RL, Lundgren J, Gordon S, Jarashow MC, Schreiber PW, Niemann S, Kohl TA, Daley CL, Stewardson AJ, Whitener CJ, Perkins K, Plachouras D, Lamagni T, Chand M, Freiberger T, Zweifel S, Sander P, Schulthess B, Scriven JE, Sax H, van Ingen J, Mestres CA, Diekema D, Brown-Elliott BA, Wallace RJ Jr, Baddour LM, Miro JM, Hoen B, Athan E, Bayer A, Barsic B, Corey GR, Chu VH, Durack DT, Fortes CQ, Fowler V, Hoen B, Krachmer AW, Durante-Magnoni E, Miro JM, Wilson WR","M. chimaera ISCVID Investigators and, ISCVID Executive Committee, Infectious Diseases Specialists, Hospital Epidemiologists, Microbiologists and Molecular Typing Specialists, Cardiac Surgeons\/ Perfusionists\/ Cardiologists, Ophthalmology, Anaesthesiologists, Public Health","Publisher: W.B. Saunders For The Hospital Infection Society Country of Publication: England NLM ID: 8007166 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-2939 (Electronic) Linking ISSN: 01956701 NLM ISO Abbreviation: J Hosp Infect Subsets: MEDLINE","Journal Article; Practice Guideline","2020-02-01","The Journal of hospital infection [J Hosp Infect] 2020 Feb; Vol. 104 (2), pp. 214-235. Date of Electronic Publication: 2019 Nov 09.","English","1532-2939","Cross Infection*\/diagnosis , Cross Infection*\/drug therapy , Cross Infection*\/microbiology , Cross Infection*\/prevention & control , Mycobacterium*\/isolation & purification , Mycobacterium Infections, Nontuberculous*\/diagnosis , Mycobacterium Infections, Nontuberculous*\/drug therapy , Mycobacterium Infections, Nontuberculous*\/prevention & control, Anti-Bacterial Agents\/therapeutic use ; Cardiac Surgical Procedures\/adverse effects ; Cardiac Surgical Procedures\/methods ; Cardiology ; Cardiopulmonary Bypass ; Communicable Diseases ; Equipment Contamination ; Humans ; Risk Factors ; Societies, Medical ; United Kingdom","Anti-Bacterial Agents therapeutic use, Cardiac Surgical Procedures adverse effects, Cardiac Surgical Procedures methods, Cardiology, Cardiopulmonary Bypass, Communicable Diseases, Equipment Contamination, Humans, Risk Factors, Societies, Medical, United Kingdom, Cross Infection diagnosis, Cross Infection drug therapy, Cross Infection microbiology, Cross Infection prevention & control, Mycobacterium isolation & purification, Mycobacterium Infections, Nontuberculous diagnosis, Mycobacterium Infections, Nontuberculous drug therapy, Mycobacterium Infections, Nontuberculous prevention & control","The Journal of hospital infection","104"]
Description
Mycobacterial infection-related morbidity and mortality in patients following cardiopulmonary bypass surgery is high and there is a growing need for a consensus-based expert opinion to provide international guidance for diagnosing, preventing and treating in these patients. In this document the International Society for Cardiovascular Infectious Diseases (ISCVID) covers aspects of prevention (field of hospital epidemiology), clinical management (infectious disease specialists, cardiac surgeons, ophthalmologists, others), laboratory diagnostics (microbiologists, molecular diagnostics), device management (perfusionists, cardiac surgeons) and public health aspects.<br /> (Copyright © 2019 The Author(s). Published by Elsevier Ltd.. All rights reserved.)
Published Date